Comorbidities in patients with multiple myeloma
Most clinicians consider performance status and comorbidities rather than chronological age in determining prognosis and treatment. Significant advancements in the treatment of myeloma have occurred including routine use of proteasome inhibitors and immunomodulatory drugs; however, the impact of com...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Kirja |
| Julkaistu: |
Zaporozhye State Medical University,
2019-08-01T00:00:00Z.
|
| Aiheet: | |
| Linkit: | Connect to this object online. |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Internet
Connect to this object online.3rd Floor Main Library
| Hyllypaikka: |
A1234.567 |
|---|---|
| Nide 1 | Saatavissa |